Start: April 1, 2019
End: August 31, 2023
This study will evaluate the long-term effects of a treatment using light on cognition, sleep, and metabolism in people with mild cognitive impairment (MCI), mild Alzheimer's disease, or a related dementia. Participants will be randomly assigned to receive either a tailored light intervention or a placebo treatment at home for six months. The intervention will provide daily stimulation with bluish-white (experimental) or yellow-white (control) light sources that are tuned to the sensitivity of the circadian system, which controls the human sleep-wake cycle. Researchers will measure if the intervention can reduce sleep disturbances, inflammation, insulin sensitivity, and improve glucose metabolism and cognition.
Minimum Age: 55 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
New Brunswick, NJ 08854
RecruitingChristoph Buettner, MD
Icahn School of Medicine at Mount Sinai
New York, NY 10029
RecruitingChristoph Buettner, MD, PhD
Lead: Rensselaer Polytechnic Institute
Source: ClinicalTrials.gov ID: NCT03933696